Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Rong Yang

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Lipids in Health and Disease|June 28, 2017
A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resectionsLu Tian, Qian Yu, Xing-Hui Gao, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma ProgressionShao-Lai Zhou, Dan Yin, Zhi-Qiang Hu, et al.
Cell Death & Disease|October 12, 2018
BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathwaysXu-Xiao Chen, Yue Yin, Jian-Wen Cheng, et al.
American Journal of Cancer Research|May 5, 2021
TM2D1 contributes the epithelial-mesenchymal transition of hepatocellular carcinoma via modulating AKT/β-catenin axisJin-Wu Hu, Yue Yin, Yang Gao, et al.
BMC Gastroenterology|December 9, 2022
Exosomal microRNAs in the DLK1-DIO3 imprinted region derived from cancer-associated fibroblasts promote progression of hepatocellular carcinoma by targeting hedgehog interacting proteinAn-Li Jin, Lin Ding, Wen-Jing Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 31, 2022
An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogrammingHua-Hua Liu, Yang Xu, Cao-Jie Li, et al.
Oncotarget|September 30, 2016
Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resectionXiao-Lu Ma, Xing-Hui Gao, Zi-Jun Gong, et al.
Journal of Clinical Laboratory Analysis|January 28, 2022
High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinomaAn-Li Jin, Yi-Hui Yang, Xi Su, et al.
Cancer Cytopathology|June 6, 2020
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resectionYun-Fan Sun, Peng-Xiang Wang, Jian-Wen Cheng, et al.
Journal of Gastroenterology and Hepatology|March 22, 2012
Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resectionHan Wu, Pei Chen, Rui Liao, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Lipids in Health and Disease|June 28, 2017
A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resectionsLu Tian, Qian Yu, Xing-Hui Gao, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma ProgressionShao-Lai Zhou, Dan Yin, Zhi-Qiang Hu, et al.
Cell Death & Disease|October 12, 2018
BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathwaysXu-Xiao Chen, Yue Yin, Jian-Wen Cheng, et al.
American Journal of Cancer Research|May 5, 2021
TM2D1 contributes the epithelial-mesenchymal transition of hepatocellular carcinoma via modulating AKT/β-catenin axisJin-Wu Hu, Yue Yin, Yang Gao, et al.
BMC Gastroenterology|December 9, 2022
Exosomal microRNAs in the DLK1-DIO3 imprinted region derived from cancer-associated fibroblasts promote progression of hepatocellular carcinoma by targeting hedgehog interacting proteinAn-Li Jin, Lin Ding, Wen-Jing Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 31, 2022
An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogrammingHua-Hua Liu, Yang Xu, Cao-Jie Li, et al.
Oncotarget|September 30, 2016
Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resectionXiao-Lu Ma, Xing-Hui Gao, Zi-Jun Gong, et al.
Journal of Clinical Laboratory Analysis|January 28, 2022
High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinomaAn-Li Jin, Yi-Hui Yang, Xi Su, et al.
Cancer Cytopathology|June 6, 2020
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resectionYun-Fan Sun, Peng-Xiang Wang, Jian-Wen Cheng, et al.
Journal of Gastroenterology and Hepatology|March 22, 2012
Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resectionHan Wu, Pei Chen, Rui Liao, et al.
Pageof 12